Else Nutrition Holdings AI Stock Analysis
Else Nutrition Holdings (0YL1) AI Stock Analysis
Else Nutrition Holdings
(Frankfurt:0YL1)
No summary available
Else Nutrition Holdings (0YL1) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 235.53K
- Dividend Yield
- ―
- Average Volume (3M)
- 3,963
- Price to Earnings (P/E)
- -0.0
- Beta (1Y)
- -27.42
- Revenue Growth
- -31.78%
- EPS Growth
- 77.42%
- Country
- Germany
- Employees
- 12
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Else Nutrition Holdings Business Overview & Revenue Model
Company Description
Else Nutrition Holdings Inc. focuses on the creation, production, and distribution of a variety of food and nutritional items for consumers ranging from infants and toddlers to children and adults. The company primarily operates within the North Amer...
Else Nutrition Holdings Earnings Call Summary
Else Nutrition has shown significant progress in reducing costs and improving operational efficiency, with promising advancements in regulatory pathways and international growth. However, challenges such as revenue decline, negative gross margin, and inventory constraints have impacted performance.
Q2-2025 Updates
Positive Updates
Negative Updates
Company Guidance
During Else Nutrition's 2025 Second Quarter Conference Call, CEO Hamutal Yitzhak outlined several key metrics and strategic initiatives demonstrating the company's progress. The quarter saw total revenues of $1.5 million, a decrease from $2.6 million in Q2 2024, primarily due to inventory constraints and seasonal sales fluctuations. Gross profit faced a loss of $55,000, translating to a negative gross margin of -3.7%, affected by additional revenue reductions of CAD 270,000. Despite these challenges, operating expenses were significantly reduced by 60% year-over-year to $1.3 million, leading to a narrowed operating loss of $1.4 million, an improvement of 55% from the previous year. Else is targeting cash flow positivity by late 2026 or early 2027, focusing on supply chain optimization, regulatory advancements, and strategic partnerships to enhance growth and profitability.
Else Nutrition Holdings Peers Comparison
Overall Rating
TSE:JWEL69Neutral
TSE:NPRA49Neutral
TSE:BU40Underperform
TSE:HBFG40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | CAD 1.90B | 24.30 | 15.93% | 2.06% | 14.96% | 35.61% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 49Neutral | CAD 35.31M | -24.78 | 30.14% | ― | 32.91% | 55.73% | |
| 40Underperform | CAD 10.66M | -0.74 | 338.06% | ― | 556.85% | -11.49% | |
| 40Underperform | CAD 239.62M | -12.38 | -311.77% | ― | 82.33% | -570.45% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:0YL1 | Else Nutrition Holdings Inc | 0.01 | -0.67 | -98.11% | |
| TSE:BU | Burcon Nutrascience Corporation | 0.84 | -1.16 | -58.00% | |
| TSE:JWEL | Jamieson Wellness | 45.69 | 11.63 | 34.15% | |
| TSE:HBFG | Happy Belly Food Group Inc | 1.44 | -0.29 | -16.76% | |
| TSE:NPRA | Nepra Foods, Inc. | 0.28 | 0.16 | 133.33% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
